Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity - Wikidata - awgldk - TriplyDB

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

http://www.wikidata.org/entity/Q36891101

about

Acute graft-versus-host disease: a bench-to-bedside update.The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Recent advances on cellular therapies and immune modulators for graft-versus-host disease.Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system.Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.Blazing a new TRAIL in hematopoietic cell transplantation Blocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells CAR T cell therapy for multiple myeloma: where are we now and where are we headed?Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect.Impact of C-rel inhibition of cord blood-derived B-, T-, and NK cells.Exploiting Cell Death Pathways for Inducible Cell Elimination to Modulate Graft-versus-Host-Disease.

P2860

Q27687130-B321DD54-CCF2-43B2-A4DE-0A5A18D2AFA5 Q28066083-7EA41FCE-27F7-4A5F-90F5-F2B70790DEDE Q36706319-FDC77AD8-76D9-4244-9BE4-43640BD83259 Q37416883-22FBAD6C-CB76-4DDA-87ED-2DDFA59AFAA4 Q38202009-A75119CC-1E52-4BD3-9134-AD52C14E1B4F Q38246755-79C978F5-617B-491D-AC54-A62484F2C731 Q38260461-75D1E534-B900-4FE7-89ED-4F58064F69F6 Q41131801-62F5D8FA-5895-4BCF-B48B-382B1F9E8A39 Q41285619-AF912D17-CB59-4656-BE43-AF0AF96538C7 Q42428547-C4F5A448-9498-4CE6-B5AF-C24834AC57B7 Q47565827-192CED28-04E9-446F-94A4-D1257B6A46B5 Q49567330-FB1D5813-8599-4C83-B7D6-B89AB6FA076B Q51043186-A801F08F-C82C-4EFA-9515-990A86E2CD73 Q55245977-A8AB85B7-1C06-4B75-9F3D-0942DAEDA048

P2860

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

http://www.wikidata.org/entity/Q36891101

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

@en

type

label

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

@en

prefLabel

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

@en

P1433

Q36891101-D22B9B72-F90C-47CA-877D-5AC9EAE5F112

P1476

Q36891101-0DBF971F-686A-42E4-8EB5-AB18F3C4B1F2

P2093

Q36891101-05B744A3-5F19-40E4-87C1-63DD2E508154

Q36891101-09C90721-CB86-44AF-97A8-9B4B2D50D733

Q36891101-10E301DB-19DE-469E-8242-E25E52DD21F9

Q36891101-14A9C227-B8F9-4322-AC85-E8DEA73DC26F

Q36891101-17243C99-CAD8-4114-8E8B-A65A9C9E8911

Q36891101-2114BB7B-C9E0-4EA0-AC16-776429211820

Q36891101-4C880EC9-40AF-4ACD-996D-FBEC882CB99F

Q36891101-5071B8B6-12A1-480B-BC38-FD3478D70F49

Q36891101-7BE4C8BE-22FA-4B70-AC0B-265F7F3F8EE9

Q36891101-892DE3BF-7B49-49CF-ACFA-A5C78E03F54B

P2860

Q36891101-0A7643BD-872A-4F51-8A30-B5E7391A80D6

Q36891101-1C853D0C-54CD-48F6-80BF-C5BC50669ADF

Q36891101-23E8D179-58BF-45EB-8244-4B08D024B880

Q36891101-276B19ED-1775-4CAB-BED2-A7F9ECE6D2F0

Q36891101-2E6F93A7-9368-47D7-AA75-638C658AEF06

Q36891101-3A4EF6C4-D022-4ADD-8616-5B94C4055FBF

Q36891101-40001AC1-1440-4C26-ABB3-9A442C7F89D0

Q36891101-4E4780F8-5850-4C2F-8123-D3F30579C7A8

Q36891101-6510238F-F052-4BFD-A0C8-C1053B5E9286

Q36891101-6A6830B0-EE43-4FFD-8028-86A6554A7F7B

P304

Q36891101-39B03093-B6B2-4607-B0AF-B81AAC1DB8FB

P31

Q36891101-1B041228-6DE1-4370-AC23-23CCBE416E39

P356

Q36891101-2B919219-CDBA-4AB3-9A71-27404318DDCE

P407

Q36891101-71E435AB-A8F4-457D-BC3D-55F4AF3541DD

P433

Q36891101-B4253B57-818D-4EDF-A360-F53E98A5C0E7

P478

Q36891101-3417321E-99A3-4D9E-9A55-13B7EABEB75B

P50

Q36891101-C5C485B2-3453-496F-8E58-98E77F6CE319

Q36891101-C8CC4C65-5B29-41DD-AD21-845C560E66B6

Q36891101-DF2269C9-3698-4E2C-8332-277DF2C4AEF7

P577

Q36891101-A0A3446B-4003-423A-ADC9-4302E2DB3A35

P698

Q36891101-E4F4E48B-C532-4411-BB11-C1B2E6A82BD6

P932

Q36891101-401B0FD4-79C3-4419-A006-994833326DEA

P356

P1433

Journal of Clinical Investigation

P1476

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

@en

P2093

Alan M Hanash

http://www.w3.org/2001/XMLSchema#string

Amanda M Holland

http://www.w3.org/2001/XMLSchema#string

Cecilia Lezcano

http://www.w3.org/2001/XMLSchema#string

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Daniel Tannenbaum

http://www.w3.org/2001/XMLSchema#string

Durva Masih

http://www.w3.org/2001/XMLSchema#string

George F Murphy

http://www.w3.org/2001/XMLSchema#string

Jennifer J Tsai

http://www.w3.org/2001/XMLSchema#string

Kelly Piersanti

http://www.w3.org/2001/XMLSchema#string

Lauren F Young

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease

DR5 knockout mice are compromised in radiation-induced apoptosis

Mixed T cell receptor dimers harbor potentially harmful neoreactivity.

Advances in graft-versus-host disease biology and therapy.

T cells require TRAIL for optimal graft-versus-tumor activity.

Three-dimensional microscopy characterization of death receptor 5 expression by over-activated human primary CD4+ T cells and apoptosis.

P304

2654-2662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI66301

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Vladimir Ponomarev

P577

2013-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23676461

http://www.w3.org/2001/XMLSchema#string

P932

3668849

http://www.w3.org/2001/XMLSchema#string